PP
ETON icon

PDT Partners’s Eton Pharmaceutcials ETON Stock Holding History

PDT Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Hold
14,891
– – 0.03% 387
2026
Q1 		$368K Hold
14,891
– – 0.02% 447
2025
Q4 		$252K Hold
14,891
– – 0.02% 492
2025
Q3 		$324K Hold
14,891
– – 0.02% 503
2025
Q2 		$212K Sell
14,891
-10,864
-42% -$172K 0.01% 634
2025
Q1 		$334K Buy
+25,755
New +$389K 0.02% 593
2022
Q3 		– Sell
-15,355
Closed -$40K – 911
2022
Q2 		$40K Sell
15,355
-8,065
-34% -$27.1K ﹤0.01% 920
2022
Q1 		$102K Buy
+23,420
New +$92.1K 0.01% 866

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

PDT Partners's ETON Position: Q2 2026 in Review

PDT Partners held its Eton Pharmaceutcials (ETON) position steady in Q2 2026 at 14,891 shares worth $539K. The position accounts for 0.03% of the portfolio, ranked #387.

PDT Partners first reported a position in ETON in Q1 2022 and has held it in 8 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • PDT Partners held 14,891 shares of Eton Pharmaceutcials worth $539K as of Q2 2026.
  • PDT Partners left its Eton Pharmaceutcials share count unchanged in Q2 2026.
  • Eton Pharmaceutcials made up 0.03% of PDT Partners's portfolio in Q2 2026, its #387 holding.
  • PDT Partners first reported a position in Eton Pharmaceutcials in Q1 2022 and has held it in 8 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.